Asthma is a disease of the lungs that affects people of all ages and both sexes. About 1 in 13 people in the United States ...

Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types. Developments in biologic therapies for ...

Novo Holdings, a leading life science investor, today announced that it has invested in a $200M Series A launch financing for Windward Bio. Headquartered in Switzerland, Windward Bio is a ...

Benralizumab is already used in the most severe cases ... "But it’s appalling that this is the first new treatment for those suffering from asthma and COPD attacks in 50 years," she said.

Asthma affects more than 300 million people ... and Drug Administration and European Medicines Agency for the treatment of severe eosinophilic asthma. These biologics lower eosinophil numbers ...

A new test can differentiate between various types of asthma via a nasal swab. Researchers hope it can eventually help match ...

LONDON: AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that has been the standard of care for 50 years, cutting the need ...

A NEW nasal swab has been found to diagnose asthma in children far quicker than previous methods. The test, developed by American researchers, is able to diagnose specific subtypes of asthma.

Early-life infection burden is associated with an increased risk for later moderate-to-severe infections and systemic ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

NHS England and Improvement will commission treatments for patients aged less than 18 years where specific commissioning conditions within a NICE Technology Appraisal or NHS England and Improvement ...